Today, most 3D printers work in layer-by-layer fashion, resulting in slow speeds and limitations with certain materials and geometries. In contrast, Readily3D's patent-pending tomographic printers create the entire object as a volume. This results in ultra-rapid build times (30s), and the ability to print a new range of materials and geometries.
Our first product, the Tomolite printer, is dedicated to life sciences. It gently shapes sensitive cells and biomaterials into complex 3D structures with an unrivalled speed. Creating and studying biological systems has never been so easy!
Our first product, the Tomolite printer, is dedicated to life sciences. It gently shapes sensitive cells and biomaterials into complex 3D structures with an unrivalled speed. Creating and studying biological systems has never been so easy!
Location: Switzerland, Vaud, Lausanne
Employees: 1-10
Founded date: 2020
Investors 3
Mentions in press and media 24
| Date | Title | Description |
| 16.02.2026 | MIT Introduces MagMix to Reduce Cell Settling in 3D Bioprinting, Addresses Key Limitation | Researchers at the Massachusetts Institute of Technology (MIT) have created MagMix, a compact magnetic system that actively prevents cell settling during 3D bioprinting, producing more uniform and functional tissues. The innovation addresse... |
| 21.08.2025 | 18 Small Businesses Receive Phase I SBIR Funding from NIST | The U.S. Department of Commerce’s National Institute of Standards and Technology (NIST) has awarded more than $1.8 million to 18 small businesses through the Small Business Innovation Research (SBIR) program. The funding will support resear... |
| 04.08.2025 | Three life sciences startups recognized for growth potential | The Innosuisse Innovation Council was impressed by three life sciences startups that completed the Core Coaching program. In recognition of their remarkable progress, the Council awarded them the Innosuisse certificate, signaling their rea... |
| 04.03.2025 | VERIGRAFT Secures €1.2M Eurostars Grant for 3D Printed Vascular Graft Breakthrough | VERIGRAFT, a Swedish biotechnology company specializing in regenerative medicine, has been awarded a €1.2 million Eurostars grant for the PREPPER (PREcision Printed PERsonalized Tissue Therapies) project. The initiative is a collaboration w... |
| 15.02.2025 | VERIGRAFT: Pioneering the Future of 3D-Printed Arterial Grafts | In the world of biotechnology, innovation is the lifeblood. Swedish company VERIGRAFT is poised to make waves with its recent €1.2 million Eurostars grant. This funding will propel the PREPPER project, which stands for Precision Printed Per... |
| 14.02.2025 | BioTech startup VERIGRAFT secures €1.2 million to advance 3D-printed arterial grafts | Gothenburg-based BioTech company VERIGRAFT has been awarded a €1.2 million Eurostars grant to lead the Precision Printed Personalised Tissue Therapies (PREPPER) project, aiming to develop next-generation 3D-printed arterial grafts. This ini... |
| 14.02.2025 | Swedish biotech VERIGRAFT secures €1.2M from Eurostars to advance 3D-printed arterial grafts | Swedish biotech VERIGRAFT has been awarded a €1.2 million Eurostars grant to lead PREPPER (PREcision Printed PERsonalised Tissue Therapies), a groundbreaking project developing next-generation 3D-printed arterial grafts. PREPPER aims to ove... |
| 07.02.2024 | Three Swiss startups secure European grants | EPFL spinoff Readily3D develops ultra-rapid, user-friendly 3D printers to make research in biosciences quicker and more efficient. Their volumetric printing technology enables the fabrication of complex structures in seconds. Readily3D par... |
| 04.05.2023 | Bearmind ravit le Trophée PERL 2023 | Quelque 250 personnes étaient réunies ce soir à Beaulieu-Lausanne pour découvrir le palmarès des PERL 2023, un élément central du soutien de Lausanne Région aux entreprises innovantes établies sur le territoire de ses 27 communes membres. D... |
| 26.04.2023 | Les cinq Finalistes du Prix PERL 2023 sont là! |
Show more